1. An enzyme isolated from artenes transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation;Moncada, S.; Gryglewski, R.; Bunting, S.; Vane, JR;Nature,1976
2. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides;Gryglewski, R.J.; Bunting, S.; Moncada, S.; Flower, R.J.; Vane, JR;Prostaglandins,1976
3. Human arterial and venous tissues generate prostacyclin (prostaglandin X) a potent inhibitor of platelet aggregation;Moncada, S.; Higgs, E.A.; Vane, JR;Lancet,1977
4. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits;Gryglewski, R.J.; Dembiniska-Kiec, A.; Zmuda, A.; Gryglewska, T.;Atherosclerosis,1978
5. Prostacyclin (PGI2)-generation by different types of human atherosclerotic lesions;Sinzinger, H.; Feigl, W.; Silberbauer, K.; Oppolzer, R.; Winter, M.; Auerswald, W.;Exp Pathol,1980